These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6806805)

  • 41. [Characteristics of infiltrative pulmonary tuberculosis located in the inferior lobe].
    Andriushina KM; Borodina NV; Savenkova DI; Oliferovskaia RP
    Klin Med (Mosk); 1985 Dec; 63(12):48-50. PubMed ID: 3937943
    [No Abstract]   [Full Text] [Related]  

  • 42. [Can we confirm that tuberculosis has been cured?].
    Ursov IG
    Probl Tuberk; 1991; (5):18-20. PubMed ID: 1924234
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diagnosis and treatment of acute progressive tuberculosis types].
    Khomenko AG; Mishin VI
    Probl Tuberk; 1996; (5):21-3. PubMed ID: 8984482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
    Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Characteristics of the filterable forms of Mycobacterium tuberculosis and their significance in pathology].
    Golyshevskaia VI; Zemskova ZS; Korolev MB
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):23-7. PubMed ID: 6431716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 48. [Systematic research on asymptomatic bacilluria in 120 non selected cases of pulmonary tuberculosis].
    Favez G; Nicca B; Pressia O
    Schweiz Med Wochenschr; 1972 Jun; 102(25):877-80. PubMed ID: 4624459
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dynamics of the rosette formation indices in the experimental tuberculosis chemotherapy process].
    Sibirnaia RI
    Probl Tuberk; 1981 Jun; (6):54-7. PubMed ID: 7279911
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical and epidemiological aspects of controlled short-term chemotherapy].
    Khomenko AG
    Probl Tuberk; 1998; (4):16-20. PubMed ID: 9771030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Biological characteristics of M. tuberculosis and difficulties in microbiological diagnosis of tuberculosis].
    Golyshevskaia VI; Korneev AA; Chernousova LN; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (2):30-2. PubMed ID: 7777459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV
    Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of action of antituberculosis drugs in standard and short-course chemotherapy regimens.
    Grosset J
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):108-15. PubMed ID: 2999946
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug therapy of tuberculosis: history and present-day status].
    Khomenko AG
    Probl Tuberk; 1996; (3):2-6. PubMed ID: 8754862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy].
    Khomenko AG; Vasil'eva IA
    Probl Tuberk; 1996; (6):52-4. PubMed ID: 9019772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.